BMS-593214
Modify Date: 2024-03-03 13:51:33
BMS-593214 structure
|
Common Name | BMS-593214 | ||
|---|---|---|---|---|
| CAS Number | 1004551-40-9 | Molecular Weight | 505.56400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C31H27N3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BMS-593214BMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT)[1]. |
| Name | 4-[2-[(6R,6aR,11bR)-2-carbamimidoyl-6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolin-6-yl]-5-hydroxy-4-methoxyphenyl]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | BMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H27N3O4 |
|---|---|
| Molecular Weight | 505.56400 |
| Exact Mass | 505.20000 |
| PSA | 128.66000 |
| LogP | 6.45910 |
| unii-xd269g3o31 |
| 1ge |